Arkolith/Insider Trading/RGNX/Form 4

Simpson Curran

Chief Executive Officer, DirectorREGENXBIO Inc. (RGNX) · full profile →Form 4 · filed Aug 5, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 1, 2024Sell(S)100$15.00$2K170K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-006014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML